Enovis Basic EPS 2010-2024 | ENOV
Enovis basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Enovis Annual Basic EPS | |
|---|---|
| 2024 | $-14.93 |
| 2023 | $-0.61 |
| 2022 | $-0.25 |
| 2021 | $1.40 |
| 2020 | $0.93 |
| 2019 | $-11.67 |
| 2018 | $3.51 |
| 2017 | $3.69 |
| 2016 | $3.12 |
| 2015 | $4.05 |
| 2014 | $9.18 |
| 2013 | $4.68 |
| 2012 | $-2.76 |
| 2011 | $0.30 |
| 2010 | $1.11 |
| 2009 | $1.65 |
| Enovis Quarterly Basic EPS | |
|---|---|
| 2024-12-31 | $-12.69 |
| 2024-09-30 | $-0.58 |
| 2024-06-30 | $-0.34 |
| 2024-03-31 | $-1.32 |
| 2023-12-31 | $0.05 |
| 2023-09-30 | $-0.05 |
| 2023-06-30 | $-0.18 |
| 2023-03-31 | $-0.43 |
| 2022-12-31 | $-0.72 |
| 2022-09-30 | $-1.23 |
| 2022-06-30 | $1.42 |
| 2022-03-31 | $0.28 |
| 2021-12-31 | $-0.06 |
| 2021-09-30 | $0.49 |
| 2021-06-30 | $0.56 |
| 2021-03-31 | $0.41 |
| 2020-12-31 | $0.72 |
| 2020-09-30 | $0.30 |
| 2020-06-30 | $-0.18 |
| 2020-03-31 | $0.09 |
| 2019-12-31 | $-0.39 |
| 2019-09-30 | $0.24 |
| 2019-06-30 | $-10.35 |
| 2019-03-31 | $-1.17 |
| 2018-12-31 | $1.17 |
| 2018-09-30 | $0.81 |
| 2018-06-30 | $0.93 |
| 2018-03-31 | $0.60 |
| 2017-12-31 | $0.36 |
| 2017-09-30 | $1.11 |
| 2017-06-30 | $1.29 |
| 2017-03-31 | $0.93 |
| 2016-12-31 | $0.93 |
| 2016-09-30 | $0.69 |
| 2016-06-30 | $0.96 |
| 2016-03-31 | $0.54 |
| 2015-12-31 | $1.05 |
| 2015-09-30 | $0.45 |
| 2015-06-30 | $1.29 |
| 2015-03-31 | $1.26 |
| 2014-12-31 | $2.10 |
| 2014-09-30 | $1.77 |
| 2014-06-30 | $4.65 |
| 2014-03-31 | $0.66 |
| 2013-12-31 | $0.99 |
| 2013-09-30 | $1.47 |
| 2013-06-30 | $1.59 |
| 2013-03-31 | $0.63 |
| 2012-12-31 | $0.90 |
| 2012-09-30 | $0.12 |
| 2012-06-30 | $0.21 |
| 2012-03-31 | $-3.99 |
| 2011-12-31 | $-1.11 |
| 2011-09-30 | $0.24 |
| 2011-06-30 | $0.72 |
| 2011-03-31 | $0.45 |
| 2010-12-31 | $0.60 |
| 2010-09-30 | $0.39 |
| 2010-06-30 | $0.15 |
| 2010-03-31 | $-0.03 |
| 2009-12-31 | $0.48 |
| 2009-09-30 | $0.39 |
| 2009-06-30 | $0.30 |
| 2009-03-31 | $0.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.994B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |